Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMC Strategy vs TAU in MDD
NCT00974155Phase 4Completed
- Start
- Sep 2009
- Primary completion
- May 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of venlafaxine, lithium, Escitalopram oxalate oral solution in major depressive disorder (MDD). Started Sep 2009; status: completed.
02
Drugs
venlafaxinelithiumEscitalopram oxalate oral solution
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00974155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974155.